2019 News Releases
2019 News Releases
King of Prussia, Pa.
Unique portfolio mix of plasma, cell and gene therapy, recombinant proteins and antibody assets highlighted at Research & Development Briefing
Sydney, Australia
King of Prussia, Pa.
Top 100 CEO rankings based on financial performance as well as environmental, social, and governance (ESG) ratings
MADRID, Spain
• Focuses on Patients Through Disease Awareness Support Activities
• Hosts Patient-Focused Symposium on Alpha 1 Management
Melbourne, Australia
- Novel real world evidence for AFSTYLA® [Antihemophilic Factor (Recombinant), Single Chain] and IDELVION® ® [Coagulation Factor IX (Recombinant), Albumin Fusion Protein] to be highlighted
Genoa, Italy
- Eight posters including one oral presentation support ongoing research and clinical experience with Hizentra®, the first and only subcutaneous immunoglobulin (Ig) therapy approved to address the unique needs of CIDP patients.
- Presentations include new analysis from the PATH (Polyneuropathy and Treatment with Hizentra) study, the largest clinical trial in CIDP.
Recipients from the US and Netherlands will be recognized in Marburg, Germany on Friday, 24 May
Dr. McKenzie will be accountable for leading CSL’s global end-to-end supply chain organization and its accompanying strategy.
New vial options deliver on CSL Behring’s heritage of innovation by providing more alternatives to patients
Leading global biotech company brings innovative therapies for life-threatening medical conditions to UAE
CSL Behring announced today that Japan’s Ministry of Health, Labour and Welfare has approved two of its immunoglobulin therapies for the treatment of patients with chronic inflammatory demyelinating polyradiculoneuropathy (CIDP): Hizentra® and Privigen®
Reinforces Commitment to Providing Global Bleeding Disorders Community with Access to Care and Efforts to Increase Awareness
Forbes Recognizes the Global Biotechnology Leader in its Top 50 Best Employers for Diversity 2019
CSL announced that it will present at the 2019 J.P. Morgan Annual Healthcare Conference.